Monteleukast Versus Inhaled Mometasone for Treatment of Otitis Media With Effusion in Children

Last updated: September 2, 2015
Sponsor: Hormozgan University of Medical Sciences
Overall Status: Completed

Phase

3

Condition

Otitis Media

Soft Tissue Infections

Ear Infections

Treatment

N/A

Clinical Study ID

NCT02541760
163
  • Ages 2-6
  • All Genders

Study Summary

Otitis media is one of the most common infections among children and is a complication in about 30% of common colds. The most common complication of acute otitis media is otitis media with effusion. Some studies have reported the effects of montelukast and mometasone nasal spray in treatment of otitis media with effusion. However, current information is inadequate in this issue. The aim of this study was to compare the effectiveness of montelukast and mometasone nasal spray in treatment of otitis media with effusion in children attending Koodakan hospital in Bandar Abbas, Iran.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • • Children who were between 2 to 6 years old

  • Definite diagnosis of OME with symptoms and examination

Exclusion

Exclusion Criteria:

  • • Currently were using corticosteroids or prophylactic monteleukast

  • Chronic pulmonary or cardiac diseases or immune deficiency

  • Allergic rhinitis

  • Hypersensitivity to monteleukast or corticosteroids

  • Avoidance of parents to fill the written informed consent

Study Design

Total Participants: 143
Study Start date:
April 01, 2014
Estimated Completion Date:
April 30, 2015

Connect with a study center

  • Hormozgan University of Medical Sciences

    Bandar Abbas, Hormozgan 097145-3388
    Iran, Islamic Republic of

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.